Drugmakers sign letter supporting FDA and calling for reversal of Texas judge’s mifepristone ruling

 Pfizer CEO Albert Bourla and dozens of other biotech and pharmaceutical company leaders have signed an open letter in support of the US Food and Drug Administration’s authority “to approve